Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS
Przemyslaw Holko, Pawal KawalecHTA Centre, Kraków, PolandAims: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR® TS from the public payer (National Health Fund [NHF]) and payer (patient and NHF) perspectives over a 26-year...
Guardado en:
Autores principales: | Przemyslaw Holko, Pawal Kawalec |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f89ebbbb2d884ad4a2f677dfe89c6847 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
por: Evans M, et al.
Publicado: (2015) -
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
por: Karen Barnard, et al.
Publicado: (2010) -
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
por: Huber CA, et al.
Publicado: (2014) -
The impact of brief high-intensity exercise on blood glucose levels
por: Adams OP
Publicado: (2013) -
Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans
por: Nakanishi S, et al.
Publicado: (2013)